Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Gross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

CollPlant Biotechnologies (CLGN) Cost of Revenue (2017 - 2025)

CollPlant Biotechnologies filings provide 9 years of Cost of Revenue readings, the most recent being $192000.0 for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 29.41% to $192000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $835000.0, a 48.62% decrease, with the full-year FY2025 number at $835000.0, down 48.62% from a year prior.
  • Cost of Revenue hit $192000.0 in Q4 2025 for CollPlant Biotechnologies, down from $269000.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $886000.0 in Q1 2021 to a low of $31000.0 in Q1 2022.
  • Median Cost of Revenue over the past 5 years was $272000.0 (2024), compared with a mean of $342800.0.
  • Biggest five-year swings in Cost of Revenue: soared 9754.27% in 2021 and later tumbled 96.5% in 2022.
  • CollPlant Biotechnologies' Cost of Revenue stood at $548000.0 in 2021, then crashed by 88.69% to $62000.0 in 2022, then soared by 1146.77% to $773000.0 in 2023, then tumbled by 64.81% to $272000.0 in 2024, then fell by 29.41% to $192000.0 in 2025.
  • The last three reported values for Cost of Revenue were $192000.0 (Q4 2025), $269000.0 (Q3 2025), and $186000.0 (Q2 2025) per Business Quant data.